SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort studyGS Collaborative, COVIDSurg CollaborativeAnaesthesia 77 (1), 28 | 2 | 2022 |
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc …S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, …The Lancet Diabetes & Endocrinology | 1 | 2021 |
TAMIS management of large peritoneal entry for recurrent rectal polyp: A video vignetteM Flanagan, JM Ryan, T Connelly, F Cooke, P McCullough, P NearyColorectal Disease | | 2021 |
Internal Hernia Through Petersen’s Defect 13 Years Post Gastrectomy+ Roux‐En‐YB Rigney, M Flanagan, P McCullough, P Neary, F CookeColorectal Disease | | 2021 |
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future DiseaseK McKernan, AM Kyriakopoulos, PA McCulloughOSF Preprints | 1 | 2021 |
Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort studyCOVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, …Anaesthesia 76 (11), 1454-1464 | 5 | 2021 |
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients …KU Eckardt, R Agarwal, YM Farag, AG Jardine, Z Khawaja, MJ Koury, …Nephrology Dialysis Transplantation 36 (11), 2039-2048 | 8 | 2021 |
Haematological splenectomy in University Hospital Waterford: A 10‐year audit and video vignetteJM Ryan, T Connelly, A Bryan, P McCullough, P Neary, F CookeColorectal Disease | | 2021 |
Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on HemodialysisBA Koplan, WC Winkelmayer, AI Costea, P Roy-Chaudhury, JA Tumlin, …Kidney International Reports | 1 | 2021 |
Laparoscopic‐assisted resection of small bowel gastrointestinal stromal tumours–A video vignetteJM Ryan, R Hill, M Flanagan, P McCullough, F Cooke, P NearyColorectal Disease | | 2021 |
A Report on Myocarditis Adverse Events in the US Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological ProductsJ Rose, PA McCulloughCurrent problems in cardiology | 1 | 2021 |
Role of hydroxychloroquine in multidrug treatment of COVID-19PA McCullough, RB Stricker, HA RischReviews in Cardiovascular Medicine 22 (3), 545-546 | | 2021 |
Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United StatesJL Jezmir, M Bharadwaj, A Chaitoff, B Diephuis, CP Crowley, SP Kishore, …Cell Reports Medicine 2 (9), 100376 | 2 | 2021 |
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19AD Santin, DE Scheim, PA McCullough, M Yagisawa, TJ BorodyNew microbes and new infections 43, 100924 | 9 | 2021 |
Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fractionPA McCullough, HS Mehta, CM Barker, J Van Houten, S Mollenkopf, …Clinical Cardiology 44 (9), 1192-1198 | | 2021 |
Synthetic mRNAs; Their Analogue Caps and Contribution to DiseaseAM Kyriakopoulos, PA McCulloughDiseases 9 (3), 57 | 1 | 2021 |
Gallstone ileus in an elderly orthopaedic patient managed with enterolithotomy: A video vignette.JM Ryan, M Flanagan, T Connelly, F Cooke, P McCullough, P NearyColorectal Disease: the Official Journal of the Association of … | | 2021 |
Impact of renin–angiotensin–aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestationsA Palazzuoli, KM Tecson, PA McCulloughJournal of Hypertension 39 (8), 1725-1726 | | 2021 |
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residentsPE Alexander, R Armstrong, G Fareed, J Lotus, R Oskoui, C Prodromos, …Medical hypotheses 153, 110622 | 5 | 2021 |
Pulmonary Tuberculosis Coexisting with Lung Adenocarcinoma ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (7), E440-E441 | | 2021 |
Nomenclature for Kidney Function from KDIGO: Shortcomings of Terminology OversimplificationA Palazzuoli, KM Tecson, C Ronco, PA McCulloughCardiorenal Medicine, 1-4 | | 2021 |
Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trialCSP Lam, A Giczewska, K Sliwa, F Edelmann, J Refsgaard, E Bocchi, …Jama Cardiology 6 (6), 706-712 | 9 | 2021 |
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort studyCOVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, …Anaesthesia 76 (6), 748-758 | 127 | 2021 |
Phosphate control: The next frontier in dialysis cardiovascular mortalityPA McCulloughCardioRenal Med 11 (3), 123-132 | 1 | 2021 |
Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fractionPA McCullough, HS Mehta, CM Barker, JV Houten, S Mollenkopf, …Journal of comparative effectiveness research 10 (14), 1055-1063 | | 2021 |
Nomenclature in nephrology: preserving ‘renal’and ‘nephro’in the glossary of kidney health and diseaseK Kalantar-Zadeh, PA McCullough, SK Agarwal, S Beddhu, M Boaz, …Journal of nephrology 34 (3), 639-648 | 5 | 2021 |
SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developersR Bruno, PA Mccullough, TFI Vila, A Henrion-Caude, T García-Gasca, …Authorea Preprints | | 2021 |
Cardio-nephrology from the point of view of the cardiologist: no more agree to disagree—getting to “yes” for every patientA Burlacu, PA McCullough, A CovicClinical Kidney Journal | 2 | 2021 |
Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before versus During the COVID-19 PandemicA Aldujeli, A Hamadeh, KM Tecson, Z Krivickas, L Maciulevicius, …The American Journal of Cardiology 147, 16-22 | 4 | 2021 |
MORTALITY AND GUIDELINE DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION: EVIDENCE FROM REAL WORLD DATAPA McCullough, H Mehta, C Barker, J Van Houten, S Mollenkopf, …Journal of the American College of Cardiology 77 (18_Supplement_1), 670-670 | | 2021 |
Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (5), E346-E347 | | 2021 |
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: design and baseline characteristicsGM Chertow, PE Pergola, R Agarwal, GA Block, YMK Farag, AG Jardine, …American heart journal 235, 1-11 | 4 | 2021 |
Vadadustat in patients with anemia and non–dialysis-dependent CKDGM Chertow, PE Pergola, YMK Farag, R Agarwal, S Arnold, G Bako, …New England Journal of Medicine 384 (17), 1589-1600 | 22 | 2021 |
Safety and efficacy of vadadustat for anemia in patients undergoing dialysisKU Eckardt, R Agarwal, A Aswad, A Awad, GA Block, MR Bacci, …New England Journal of Medicine 384 (17), 1601-1612 | 21 | 2021 |
Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney DiseaseJH Ishida, C Chauhan, B Gillespie, K Gruchalla, PA McCullough, S Quella, …Clinical Journal of the American Society of Nephrology | | 2021 |
Effect of combined renin angiotensin aldosterone inhibitors and diuretic treatment among patients hospitalized with SARS-CoV-2 Infection COVID-19A Palazzuoli, KM Tecson, M Vicenzi, F D’Ascenzo, GM De Ferrari, … | | 2021 |
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional CardiologistsC Valdenor, PA McCullough, D Paculdo, MC Acelajado, JR Dahlen, …Current Problems in Cardiology, 100851 | | 2021 |
Sore Mouth ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (4) | | 2021 |
Anemia of cardiorenal syndromePA McCulloughKidney International Supplements 11 (1), 35-45 | 1 | 2021 |
Comparison of Survival in Patients With Clinically Significant Tricuspid Regurgitation With and Without Heart Failure (From the Optum Integrated File)CM Barker, DP Cork, PA McCullough, HS Mehta, J Van Houten, …The American Journal of Cardiology 144, 125-130 | 1 | 2021 |
SARS-CoV-2 infection and the COVID-19 pandemic: a call to action for therapy and interventions to resolve the crisis of hospitalization, death, and handle the aftermathPA McCullough, K VijayReviews in cardiovascular medicine 22 (1), 9-10 | 2 | 2021 |
Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection FractionPA McCullough, G Rahimi, KM TecsonJournal of the American College of Cardiology 77 (9), 1222-1224 | | 2021 |
Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19)J Zhang, KM Tecson, PA McCulloughBaylor University Medical Center Proceedings 34 (2), 262-268 | 1 | 2021 |
Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (3), E222-E223 | | 2021 |
Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)G Rahimi, KM Tecson, O Elsaid, PA McCulloughThe American Journal of Cardiology 142, 91-96 | 1 | 2021 |
Screening for SARS-CoV-2 via PCR and serological testing in asymptomatic healthcare workersT Safder, PA McCullough, KR Wheelan, G Rahimi, S Zurawski, …Baylor University Medical Center Proceedings, 1-5 | 1 | 2021 |
Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United StatesJE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, …American Journal of Kidney Diseases 77 (2), 190-203. e1 | 80 | 2021 |
Early ambulatory multidrug therapy reduces hospitalization and death in high-risk patients with SARS-CoV-2 (COVID-19)B Procter, C Ross, V Pickard, E Smith, C Hanson, PA McCulloughAuthorea Preprints | 9 | 2021 |
Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemicA Palazzuoli, G Ruocco, KM Tecson, PA McCulloughHeart Failure Reviews, 1-7 | 1 | 2021 |
Discordance between estimated and measured changes in plasma volume among patients with acute heart failureJS Swolinsky, E Tuvshinbat, DM Leistner, F Edelmann, F Knebel, …ESC heart failure | | 2021 |
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, …JAMA internal medicine 181 (1), 41-51 | 224 | 2021 |
Association between delayed revascularization during the covid-19 pandemic and rates of post myocardial infarction heart failure hospitalizationsA Aldujeli, A Hamadeh, KM Tecson, Ž Krivickas, L Maciulevičius, …Heart Failure 2021 & [8th] World Congress on Acute Heart Failure: 29 June-01 … | | 2021 |
Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid ConditionsP McCullough, CS Ng, M Ryan, ER Baker, R MehtaCardiorenal medicine 11 (4), 193-199 | | 2021 |
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 PatientsS Hazan, S Dave, AW Gunaratne, S Dolai, PA McCullough, R Clancy, …medRxiv | 3 | 2021 |
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failureJS Swolinsky, NP Nerger, DM Leistner, F Edelmann, F Knebel, …ESC Heart Failure | 1 | 2021 |
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes.KB Lo, HM Toroghi, G Salacup, J Jiang, R Bhargav, E Quintero, …MedReviews, LLC 22 (1), 199 | 3 | 2021 |
Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home ResidentsPE Alexander, R Armstrong, G Fareed, K Gill, J Lotus, R Oskoui, …medRxiv | | 2021 |
Regarding:“Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019”PA McCulloughAnnals of Medicine 53 (1), 286-286 | 1 | 2021 |
The Low-Density Lipoprotein Cholesterol Hypothesis: An UpdateR Rengarajan, KM Tecson, PA McCulloughTherapeutic Lipidology, 121-138 | | 2021 |
Implications of Chronic Kidney Disease on the Epidemiology of Cardiovascular DiseasePA McCullough, AY KlugerTextbook of Cardiorenal Medicine, 1-5 | | 2021 |
Novel Biomarkers of Chronic Cardiorenal DiseasePA McCulloughTextbook of Cardiorenal Medicine, 227-233 | | 2021 |
Type 2 Cardiorenal SyndromeN Rocha, PA McCulloughTextbook of Cardiorenal Medicine, 75-94 | | 2021 |
Textbook of Cardiorenal MedicinePA McCullough, C RoncoSpringer | | 2021 |
Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infectionPA McCullough, RJ Kelly, G Ruocco, E Lerma, J Tumlin, KR Wheelan, …The American journal of medicine 134 (1), 16-22 | 87 | 2021 |
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative …SD Roger, PT Lavin, EV Lerma, PA McCullough, J Butler, BS Spinowitz, …Nephrology Dialysis Transplantation 36 (1), 137-150 | 18 | 2021 |
Class effects of SGLT2 inhibitors on cardiorenal outcomesAY KlugerTextbook of Cardiorenal Medicine, 279-294 | 89 | 2021 |
Early multidrug regimens in new potentially fatal medical problemsPA McCullough, R OskouiReviews in cardiovascular medicine 21 (4), 507-508 | 4 | 2020 |
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infectionBC Procter, C Ross, V Pickard, E Smith, C Hanson, PA McCulloughReviews in cardiovascular medicine 21 (4), 611-614 | 26 | 2020 |
Mortality risk assessment using CHA (2) DS (2)-VASc scores in patients hospitalized with coronavirus disease 2019 infectionG Ruocco, PA McCullough, KM Tecson, M Mancone, GM De Ferrari, …The American Journal of Cardiology 137, 111-117 | 16 | 2020 |
The Plasma Metabolome is Significantly Altered in HypercholesterolemiaT Bottiglieri, E Arning, KM Tecson, PA McCulloughCIRCULATION RESEARCH 127 (12), E279-E279 | | 2020 |
265 Incidence, determinants and prognostic relevance of HS-troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patientsL Arcari, M Luciano, L Cacciotti, MB Musumeci, V Spuntarelli, E Pistella, …European Heart Journal Supplements 22 (Supplement_N), N65-N79 | | 2020 |
Delays in presentation in patients with acute myocardial infarction during the COVID-19 pandemicA Aldujeli, A Hamadeh, K Briedis, KM Tecson, J Rutland, Z Krivickas, …Cardiology Research 11 (6), 386 | 24 | 2020 |
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysisKB Lo, R Bhargav, G Salacup, J Pelayo, J Albano, PA McCullough, …Expert Review of Cardiovascular Therapy 18 (12), 919-930 | 21 | 2020 |
Acute coronary syndromes in the peri‐operative period after kidney transplantation in United StatesA Goyal, KB Lo, K Chatterjee, RO Mathew, PA McCullough, S Bangalore, …Clinical Transplantation 34 (12), e14083 | 2 | 2020 |
Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 SyndromeA Palazzuoli, M Mancone, GM De Ferrari, G Forleo, GG Secco, …Journal of the American Heart Association 9 (22), e017364 | 20 | 2020 |
Favipiravir and the need for early ambulatory treatment of SARS-CoV-2 infection (COVID-19)PA McCulloughAntimicrobial Agents and Chemotherapy 64 (12), e02017-20 | 24 | 2020 |
Relation of Transthoracic Echocardiographic Aortic Regurgitation to Pressure Half-time and All-Cause Mortality………………………………… 113 Jordan B. Strom, Eli V …CA Tsao, WJ Manning, P Galazka, R Jain, L Muthukumar, H Sanders, …The American Journal of Cardiology 135 | | 2020 |
Ventricular fibrillation storm in coronavirus 2019O Elsaid, PA McCullough, KM Tecson, RS Williams, A YoonThe American Journal of Cardiology 135, 177-180 | 16 | 2020 |
Factors associated with death in critically ill patients with coronavirus disease 2019 in the USS Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, …JAMA internal medicine 180 (11), 1436-1447 | 506 | 2020 |
Outcomes of critically ill solid organ transplant patients with COVID‐19 in the United StatesMZ Molnar, A Bhalla, A Azhar, M Tsujita, M Talwar, V Balaraman, A Sodhi, …American Journal of Transplantation 20 (11), 3061-3071 | 71 | 2020 |
A novel strategy to prevent contrast nephropathy:“Continuous hemodiafiltration”PA McCullough, JA GoldsteinCatheterization and Cardiovascular Interventions 96 (6), 1182-1183 | | 2020 |
TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic TherapyA Hamadeh, A Aldujeli, K Briedis, K Tecson, JS Sanchez, M Al Dujeili, …Journal of the American College of Cardiology 76 (17 Supplement S), B89-B90 | | 2020 |
Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart AssociationJ Rangaswami, V Bhalla, IH de Boer, A Staruschenko, JA Sharp, …Circulation 142 (17), e265-e286 | 43 | 2020 |
COVID-19-associated systemic thromboembolism: a case report and review of the literatureP Mahajan, B Dass, N Radhakrishnan, PA McCulloughCardiorenal medicine, 1-8 | 13 | 2020 |
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failureCM Barker, DP Cork, PA McCullough, HS Mehta, JV Houten, …Journal of Comparative Effectiveness Research 10 (1), 29-37 | | 2020 |
Current overview on hypercoagulability in COVID-19N Singhania, S Bansal, DP Nimmatoori, AA Ejaz, PA McCullough, …American Journal of Cardiovascular Drugs 20 (5), 393-403 | 109 | 2020 |
Ventricular septal myectomy for the treatment of left ventricular outflow tract obstruction due to Fabry diseaseB Raju, CS Roberts, M Sathyamoorthy, R Schiffman, C Swift, …The American Journal of Cardiology 132, 160-164 | 1 | 2020 |
Usefulness of coronary angiography in patients with left atrial myxomaCE Velasco, NP Suarez, CP Roullard, PA McCullough, WC RobertsBaylor University Medical Center Proceedings 33 (4), 529-531 | | 2020 |
Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathyJ Zhang, KM Tecson, PA McCulloughReviews in cardiovascular medicine 21 (3), 315-319 | 68 | 2020 |
Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19J Zhang, PA McCullough, KM TecsonReviews in cardiovascular medicine 21 (3), 339-344 | 23 | 2020 |
Characteristics and outcomes in patients presenting with COVID-19 and ST-segment elevation myocardial infarctionA Hamadeh, A Aldujeli, K Briedis, KM Tecson, J Sanz-Sánchez, …The American journal of cardiology 131, 1-6 | 49 | 2020 |
Inpatient mortality according to level of respiratory support received for severe acute respiratory syndrome coronavirus 2 (Coronavirus Disease 2019) infection: a prospective …A Palazzuoli, F Ruberto, GM De Ferrari, G Forleo, GG Secco, GM Ruocco, …Critical Care Explorations 2 (9) | 4 | 2020 |
Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patientsDP Cork, PA McCullough, HS Mehta, CM Barker, C Gunnarsson, …ESC heart failure 7 (4), 1502-1509 | 2 | 2020 |
Analysing risk in heart failure: a K alium checkRT Glenister, PA McCulloughEuropean journal of heart failure 22 (8), 1412-1414 | | 2020 |
Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptomsF Gul, KB Lo, J Peterson, PA McCullough, A Goyal, J RangaswamiBaylor University Medical Center Proceedings 33 (3), 366-369 | 11 | 2020 |
Disconnect between community testing and hospitalization for SARS-CoV-2 (COVID-19) infectionPA McCullough, J ArunthamakunBaylor University Medical Center Proceedings 33 (3), 481-481 | 5 | 2020 |
SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically illA Kazory, C Ronco, PA McCulloughBaylor University Medical Center Proceedings 33 (3), 370-375 | 39 | 2020 |
Early Statin Use and Recurrent Major Adverse Cardiovascular Events: A Multicenter StudyK Tecson, A Kluger, A Cassidy-Bushrow, B Liu, C Coleman, L Jones, …Journal of Clinical Lipidology 14 (4), 561 | | 2020 |
Considerations for management of acute coronary syndromes during the SARS-CoV-2 (COVID-19) pandemicK Briedis, A Aldujeli, M Aldujeili, K Briede, R Zaliunas, A Hamadeh, …The American journal of cardiology | 7 | 2020 |
APPLICATION OF A RISK MITIGATION STRATEGY TO PREVENT EXCESS CARDIOVASCULAR RISK IN PULMONARY HYPERTENSION: LARIAT STUDYRJ White, M Chakinala, M Chin, J Feldman, A Goldsberry, P McCullough, …NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 533-533 | | 2020 |
P0229 APPLICATION OF A RISK MITIGATION STRATEGY TO PREVENT EXCESS CARDIOVASCULAR RISK IN PULMONARY HYPERTENSION: LARIAT STUDYRJ White, M Chakinala, M Chin, J Feldman, A Goldsberry, P McCullough, …Nephrology Dialysis Transplantation 35 (Supplement_3), gfaa142. P0229 | | 2020 |
The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims databaseDP Cork, PA McCullough, HS Mehta, CM Barker, J Van Houten, …Journal of medical economics 23 (5), 521-528 | 4 | 2020 |
Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal AxisKB Lo, PA McCullough, J RangaswamiHeart Failure 8 (5), 426-426 | 1 | 2020 |
Antihypertensive drugs and risk of COVID-19?KB Lo, PA McCullough, J RangaswamiThe Lancet. Respiratory Medicine 8 (5), e29 | 20 | 2020 |
Prevention Guidelines as Failed Minimal Standards of CarePA McCulloughThe American journal of cardiology 125 (9), 1441-1442 | 1 | 2020 |
Readers’ Comments: Aspirin and/or Other Antiplatelet Agents for the Prevention of Infective EndocarditisJE MadiasThe American journal of cardiology 125 (9), 1450 | | 2020 |
Impact of durable ventricular assist device support on outcomes of patients with congenital heart disease waiting for heart transplantA Cedars, KM Tecson, AN Zaidi, A Lorts, PA McCulloughASAIO Journal 66 (5), 513-519 | 6 | 2020 |
Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for cliniciansF Ronco, G Tarantini, PA McCulloughReviews in cardiovascular medicine 21 (1), 9-23 | 12 | 2020 |
Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort studyA Agrawal, HUH Virk, I Riaz, D Jain, B Tripathi, C Krittanawong, …Reviews in cardiovascular medicine 21 (1), 123-127 | 4 | 2020 |
MEDICAL THERAPY IN PATIENTS WITH FUNCTIONAL MITRAL REGURGITATION: ARE PATIENTS OPTIMIZED IN THE REAL WORLD?H Mehta, P McCullough, DP Cork, C Barker, J Van Houten, C Gunnarsson, …Journal of the American College of Cardiology 75 (11_Supplement_1), 1322-1322 | | 2020 |
SURVIVAL IN CLINICALLY SIGNIFICANT TRICUSPID REGURGITATION PATIENTS WITH AND WITHOUT HEART FAILURE: EVIDENCE FROM OPTUM’S INTEGRATED DATABASESCM Barker, DP Cork, H Mehta, P McCullough, W Irish, J Van Houten, …Journal of the American College of Cardiology 75 (11_Supplement_1), 1319-1319 | | 2020 |
Limitations of transoesophageal echocardiogram in acute ischaemic strokeZP Rosol, KF Kopecky, BR Minehart, KM Tecson, A Vasudevan, …Open heart 7 (1), e001176 | 1 | 2020 |
Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trialA Bhangu, D Nepogodiev, N Ives, L Magill, J Glasbey, C Forde, …The Lancet 395 (10222), 417-426 | 13 | 2020 |
Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shockB Raju, PA McCulloughEuropean journal of heart failure 22 (2), 287-289 | 1 | 2020 |
Mortality risk assessment using CHA (2) DS (2)-VASC scores in patients hospitalized with COVID-19 infectionG Ruocco, P Mccullough, K Tecson, M Mancone, GM De Ferrari, …European Heart Journal Supplements, N77-N77 | | 2020 |
Kidney Disease in the Cardiac Catheterization Laboratory: A Practical ApproachJ Rangaswami, EV Lerma, PA McCulloughSpringer Nature | | 2020 |
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)PA McCullough, PE Alexander, R Armstrong, C Arvinte, AF Bain, …Reviews in cardiovascular medicine 21 (4), 517 | 79 | 2020 |
Randomized controlled trials of early ambulatory hydroxychloroquine in the prevention of COVID-19 infection, hospitalization, and death: meta-analysisJA Ladapo, JE McKinnon, PA McCullough, H RischMedRxiv | 21 | 2020 |
Fulminant acute kidney injury in a young patient with novel coronavirus 2019A Gopalakrishnan, A Mossaid, KB Lo, V Vasudevan, PA McCullough, …Cardiorenal medicine 10 (4), 217-222 | 17 | 2020 |
Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infectionPA McCullough, J Eidt, J Rangaswami, E Lerma, J Tumlin, K Wheelan, …Reviews in cardiovascular medicine 21 (1), 1 | 33 | 2020 |
Renal and cardiovascular effects of sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease: perspectives on the Canagliflozin …MR Weir, PA McCullough, JB Buse, J AndersonAmerican journal of nephrology 51 (4), 276-288 | 7 | 2020 |
Benefits and risks of continuing angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and mineralocorticoid receptor antagonists during …E Oliveros, ET Oni, A Shahzad, AY Kluger, KB Lo, J Rangaswami, …Cardiorenal medicine 10 (2), 69-84 | 16 | 2020 |
The effects of SGLT2 inhibitors on cardiovascular and renal outcomes in diabetic patients: a systematic review and meta-analysisKB Lo, F Gul, P Ram, AY Kluger, KM Tecson, PA McCullough, …Cardiorenal medicine 10 (1), 1-10 | 48 | 2020 |
Cardiovascular Disease and Chronic Kidney DiseaseJ Rangaswami, PA McCulloughChronic Renal Disease, 337-353 | | 2020 |
Cardiorenal syndromeS Soman, C Chitturi | 1 | 2020 |
Alterations in Doppler-derived renal venous stasis index during decompensation of right heart failure and fluid overload in a patient with pulmonary hypertensionF Husain-Syed, HW Birk, K Tello, MJ Richter, C Ronco, PA McCullough, …Reviews in cardiovascular medicine 20 (4), 263-266 | 2 | 2019 |
Arrhythmias and Conduction DisturbancesFPLA Appendage, JP Pouru, S Jaakkola, J Lund, F Biancari, A Saraste, …The American Journal of Cardiology 124 (12) | | 2019 |
The CatLet score: a new coronary angiographic scoring tool accommodating the variable coronary anatomy for the first timeMX Xu, RL Teng, TD Ruddy, P Schoenhagen, T Bartel, R Di Bartolomeo, …Journal of thoracic disease 11 (12), 5199 | 4 | 2019 |
Doppler‐derived renal venous stasis index in the prognosis of right heart failureF Husain‐Syed, HW Birk, C Ronco, T Schörmann, K Tello, MJ Richter, …Journal of the American Heart Association 8 (21), e013584 | 25 | 2019 |
First and recurrent events after percutaneous coronary intervention: implications for survival analysesA Vasudevan, JW Choi, GA Feghali, AY Kluger, SR Lander, KM Tecson, …Scandinavian Cardiovascular Journal 53 (6), 299-304 | 1 | 2019 |
PCV116 USING ADMINISTRATIVE CLAIMS DATA TO ESTIMATE THERAPEUTIC INTENSITY IN MEDICALLY MANAGED HEART FAILURE PATIENTSJ Van Houten, PA McCullough, H Mehta, C Barker, D Cork, C Gunnarsson, …Value in Health 22, S563 | | 2019 |
The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart FailurePA McCullough, HS Mehta, CM Barker, DP Cork, C Gunnarsson, …The American journal of cardiology 124 (8), 1226-1231 | | 2019 |
TCT-432 The Economic Impact of Clinically Significant Tricuspid RegurgitationP Verta, P McCullough, C Barker, D Cork, H Mehta, C Gunnarsson, …Journal of the American College of Cardiology 74 (13S), B427-B427 | | 2019 |
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved …SD Anker, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, …European journal of heart failure 21 (10), 1279-1287 | 133 | 2019 |
Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced …M Packer, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, …European journal of heart failure 21 (10), 1270-1278 | 77 | 2019 |
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseaseP Rossing, GA Block, MP Chin, A Goldsberry, HJL Heerspink, …Kidney international 96 (4), 1030-1036 | 16 | 2019 |
Continuation of chronic heart failure therapies during heart failure hospitalization-a reviewG Singhania, AA Ejaz, PA McCullough, AY Kluger, S Balamuthusamy, …IMR Press | 18 | 2019 |
The healthcare burden of disease progression in medicare patients with functional mitral regurgitationPA McCullough, HS Mehta, DP Cork, CM Barker, C Gunnarsson, …Journal of medical economics 22 (9), 909-916 | 2 | 2019 |
The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injuryA Haq, PA McCulloughAnnals of translational medicine 7 (18) | | 2019 |
Cardiovascular disease care fragmentation in kidney transplantation: a call for actionJ Rangaswami, S Bangalore, B Kaplan, KA Birdwell, AC Wiseman, …Kidney international 96 (3), 568-571 | 3 | 2019 |
Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary interventionA Vasudevan, JW Choi, GA Feghali, SR Lander, L Jialiang, JM Schussler, …Journal of Investigative Medicine 67 (6), 943-949 | 1 | 2019 |
Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 studyBS Spinowitz, S Fishbane, PE Pergola, SD Roger, EV Lerma, J Butler, …Clinical Journal of the American Society of Nephrology 14 (6), 798-809 | 88 | 2019 |
Reply: Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse OutcomesG Savarese, LH Lund, JJ CarreroJACC: Heart Failure 7 (6), 533-534 | 1 | 2019 |
Arterial stiffness in the heart disease of CKDL Zanoli, P Lentini, M Briet, P Castellino, AA House, GM London, …Journal of the American Society of Nephrology 30 (6), 918-928 | 63 | 2019 |
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAA House, C Wanner, MJ Sarnak, IL Piña, CW McIntyre, P Komenda, …Kidney international 95 (6), 1304-1317 | 114 | 2019 |
Common laboratory parameters as indicators of multi‐organ dysfunction in acute heart failureS Sudhakaran, PA McCulloughEuropean journal of heart failure 21 (6), 751-753 | | 2019 |
Development and initial validation of the PROMIS®-Plus-HF profile measureFS Ahmad, MA Kallen, KE Schifferdecker, KL Carluzzo, SE Yount, …Circulation: Heart Failure 12 (6), e005751 | 17 | 2019 |
Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson’s DiseasePA McCulloughCardiology and therapy 8 (1), 145-150 | 3 | 2019 |
PCV53 THERAPEUTIC INTENSITY ALGORITHM IS ASSOCIATED WITH ANNUAL EXPENDITURES IN MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTS WITH AND WITHOUT MITRAL REGURGITATIONJ Van Houten, D Cork, H Mehta, C Barker, P Verta, C Gunnarsson, …Value in Health 22, S128-S129 | | 2019 |
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategiesJ Rangaswami, RO Mathew, R Parasuraman, E Tantisattamo, M Lubetzky, …Nephrology Dialysis Transplantation 34 (5), 760-773 | 60 | 2019 |
American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis …J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, …Circulation 139 (16), e840-78 | 79 | 2019 |
Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart AssociationJ Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, …Circulation 139 (16), e840-e878 | 306 | 2019 |
Therapeutic Intensity in Medically Managed Incident Heart Failure Patients with and without Mitral Regurgitation: A Claims Based AnalysisPA McCullough, DP Cork, HS Mehta, CM Barker, C Gunnarsson, M Ryan, …Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A151-A151 | | 2019 |
THE HEALTHCARE BURDEN OF DISEASE PROGRESSION IN MEDICARE PATIENTS WITH FUNCTIONAL MITRAL REGURGITATIONCM Barker, J Van Houten, H Mehta, D Cork, C Gunnarsson, S Mollenkopf, …Journal of the American College of Cardiology 73 (9S1), 1051-1051 | | 2019 |
SUPERIOR SINUS VENOSUS DEFECT AND PERSISTENT LEFT-SIDED SUPERIOR VENA CAVA WITH RIGHT HEART ENLARGEMENT IN AN ASYMPTOMATIC MIDDLE-AGED WOMANA Lee, A Afzal, C Barbin, Z Rosol, A Cedars, H Wang, D Lofthus, A Rafael, …Journal of the American College of Cardiology 73 (9S1), 2513-2513 | | 2019 |
THE IMPACT OF PREOPERATIVE LENGTH OF STAY ON MAJOR ADVERSE RENAL AND CARDIAC EVENTSKM Tecson, KR Wheelan, P McCulloughJournal of the American College of Cardiology 73 (9S1), 74-74 | | 2019 |
THE ECONOMIC IMPACT OF MITRAL REGURGITATION ON MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTSDP Cork, H Mehta, C Barker, P Verta, C Gunnarsson, MP Ryan, ER Baker, …Journal of the American College of Cardiology 73 (9S1), 1130-1130 | | 2019 |
THE IMPACT OF MITRAL REGURGITATION ON MORTALITY AND HEART FAILURE ADMISSIONS IN NEWLY DIAGNOSED HEART FAILURE PATIENTSDP Cork, H Mehta, C Barker, P Verta, MP Ryan, E Baker, C Gunnarsson, …Journal of the American College of Cardiology 73 (9S1), 1131-1131 | | 2019 |
Safety and Efficacy of Sodium Zirconium Cyclosilicate for Long-Term Treatment of Hyperkalemia in Patients With Chronic Kidney Disease: Results From an Open-Label, Phase 3 StudyS Roger, P Lavin, E Lerma, PA McCullough, J Butler, B Spinowitz, …NEPHROLOGY NURSING JOURNAL 46 (2), 241-241 | | 2019 |
Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular proceduresPA McCullough, TM Todoran, ES Brilakis, MP Ryan, C GunnarssonCatheterization and Cardiovascular Interventions 93 (2), E90-E97 | 2 | 2019 |
Frequency of abnormal fractional flow reserve measurements among major coronary arteriesCM Barbin, A Vasudevan, JW Choi, PA McCullough, JM Schussler, …Cardiovascular Revascularization Medicine 20 (2), 143-146 | 1 | 2019 |
Comparison of reflex, resistance training, and core activities using change in blood pressure over time after spontaneous coronary artery dissectionK Brown, J Adams, PA McCulloughBaylor University Medical Center Proceedings 32 (1), 113-115 | 1 | 2019 |
Cardiovascular disease in patients with chronic kidney diseasePA McCullough, AY KlugerHypertension 5 (1) | 1 | 2019 |
Serial urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 and the prognosis for acute kidney injury over the course of critical …PA McCullough, M Ostermann, LG Forni, A Bihorac, JL Koyner, …Cardiorenal medicine 9 (6), 358-369 | 9 | 2019 |
Statin Update: Intolerance, Benefit, and BeyondAY Kluger, KM Tecson, S Sudhakaran, J Zhang, PA McCulloughHypertension 5 (1), 3 | | 2019 |
In-hospital mortality and major adverse cardiovascular events after kidney transplantation in the United StatesA Goyal, K Chatterjee, RO Mathew, MS Sidhu, S Bangalore, …Cardiorenal medicine 9 (1), 51-60 | 16 | 2019 |
Effects of bardoxolone methyl on magnesium in patients with type 2 diabetes mellitus and chronic kidney diseaseDV Rizk, AL Silva, PE Pergola, R Toto, DG Warnock, MP Chin, …Cardiorenal medicine 9 (5), 316-325 | 4 | 2019 |
Cardiometabolic-renal disease in South Asians: consensus recommendations from the Cardio Renal Society of AmericaK Vijayaraghavan, PA McCullough, B Singh, M Gupta, E Enas, V Mohan, …Cardiorenal medicine 9 (4), 240-251 | 2 | 2019 |
Community-acquired acute kidney injury as a risk factor of de novo heart failure hospitalizationKM Tecson, H Hashemi, A Afzal, TA Gong, P Kale, PA McCulloughCardiorenal medicine 9 (4), 252-260 | 4 | 2019 |
Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright FutureJ Rangaswami, S Soman, PA McCulloughCardiorenal medicine 9 (4), 222-228 | 2 | 2019 |
Acute Kidney Injury in Heart FailurePA McCullough, C RoncoCritical Care Nephrology, 257-263. e1 | | 2019 |
Heart-Kidney Cross-TalkPA McCullough, C RoncoCritical Care Nephrology, 664-670. e3 | | 2019 |
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agentsVH Haase, GM Chertow, GA Block, PE Pergola, EM deGoma, Z Khawaja, …Nephrology Dialysis Transplantation 34 (1), 90-99 | 57 | 2019 |
Cardiorenal Syndrome Type 5C Ronco, L Di Lullo, A BellasiCritical Care Nephrology, 704-711. e2 | | 2019 |
Key updates in Cardio-Nephrology from 2018: springboard to a bright FutureJ Rangaswami, S Soman, PA McCulloughReviews in cardiovascular medicine 19 (4), 113-116 | 5 | 2018 |
Variations in the management of significant polyps and early colorectal cancer: results from a multicentre observational study of 383 patientsM Dattani, S Crane, NJ Battersby, F Di Fabio, BP Saunders, S Dolwani, …Colorectal Disease 20 (12), 1088-1096 | 12 | 2018 |
Heart failure in end-stage kidney disease: pathophysiology, diagnosis, and therapeutic strategiesJ Rangaswami, PA McCulloughSeminars in nephrology 38 (6), 600-617 | 28 | 2018 |
Analysis of electrocardiographic intervals before and after transcatheter aortic valve implantation to predict the need for permanent pacingTN Ball, A Vasudevan, J Mi Ko, MD Assar, PA McCullough, RC StolerBaylor University Medical Center Proceedings 31 (4), 407-413 | 4 | 2018 |
Prognostic value of urinary 11‐dehydro‐thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirinA Vasudevan, KM Tecson, J Bennett‐Firmin, T Bottiglieri, LR Lopez, …Catheterization and Cardiovascular Interventions 92 (4), 653-658 | 4 | 2018 |
Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directionsS Sudhakaran, T Bottiglieri, KM Tecson, AY Kluger, PA McCulloughReviews in cardiovascular medicine 19 (3), 77-88 | 17 | 2018 |
Systemic HypertensionR Ochoa-Jimenez, K Viquez-Beita, C Daluwatte, R Zusterzeel, T Ajam, …The American Journal of Cardiology 122 (6) | | 2018 |
Renal function and exercise training in ambulatoryheart failure patients with a reduced ejection fractionAP Ambrosy, H Mulder, A Coles, WE Krauss, CSP Lam, PA McCullough, …The American journal of cardiology 122 (6), 999-1007 | 4 | 2018 |
Cardiorenal Syndrome: A Call to Action for a Pressing Medical IssuePA McCullough, S SomanAdvances in chronic kidney disease 25 (5), 379-381 | 1 | 2018 |
Effects of sodium glucose co-transporter 2 inhibitors on the kidneyN de Albuquerque Rocha, IJ Neeland, PA McCullough, RD Toto, …Diabetes and Vascular Disease Research 15 (5), 375-386 | 29 | 2018 |
Semaglutide and GLP-1 analogues as weight-loss agentsAY Kluger, PA McCulloughLancet (London, England) 392 (10148), 615-616 | 5 | 2018 |
Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failurePA McCullough, K Uhlig, JF Neylan, PE Pergola, S FishbaneThe American journal of cardiology 122 (4), 683-688 | 8 | 2018 |
Association of urinary 11-dehydro-thromboxane B2 and F2-isoprostanes with mortality in aspirin-treated stable coronary artery disease patientsL Lopez, K Dier, A Vasudevan, T Bottiglieri, P McCulloughAtherosclerosis 275, e88 | | 2018 |
Identifying suspected familial chylomicronemia syndromeR Rengarajan, PA McCullough, A Chowdhury, KM TecsonBaylor University Medical Center Proceedings 31 (3), 284-288 | 6 | 2018 |
Frequency of atrial arrhythmias after atrial flutter ablation and the effect of presenting rhythm on the day of ablationA Vasudevan, A Hundae, D Borodge, PA McCullough, PJ WellsBaylor University Medical Center Proceedings 31 (3), 280-283 | 2 | 2018 |
Inhibition of the sodium–proton antiporter (Exchanger) is a plausible mechanism of potential benefit and harm for drugs designed to block sodium glucose co-transporter 2PA McCullough, AY Kluger, KM Tecson, CM Barbin, AY Lee, EV Lerma, …Reviews in cardiovascular medicine 19 (2), 51-63 | 23 | 2018 |
Cardiorenal outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME trials: a systematic reviewAY Kluger, KM Tecson, CM Barbin, AY Lee, EV Lerma, ZP Rosol, …Reviews in cardiovascular medicine 19 (2), 41-49 | 28 | 2018 |
Bioimpedance-guided hydration for the prevention of contrast-induced kidney injury: the HYDRA studyM Maioli, A Toso, M Leoncini, N Musilli, G Grippo, C Ronco, …Journal of the American College of Cardiology 71 (25), 2880-2889 | 41 | 2018 |
Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conferenceMP Turakhia, PJ Blankestijn, JJ Carrero, CM Clase, R Deo, CA Herzog, …European heart journal 39 (24), 2314-2325 | 132 | 2018 |
Robertsonian Perspectives on Atherosclerosis: The Power of Direct ObservationPA McCulloughAmerican Journal of Cardiology 121 (11), 1441 | | 2018 |
Major adverse renal and cardiac events after coronary angiography and cardiac surgeryKM Tecson, D Brown, JW Choi, G Feghali, GV Gonzalez-Stawinski, …The Annals of thoracic surgery 105 (6), 1724-1730 | 15 | 2018 |
Cardiovascular risk reduction in patients with chronic kidney disease: potential for targeting inflammation with canakinumabDZI Cherney, Y Lytvyn, PA McCulloughJournal of the American College of Cardiology 71 (21), 2415-2418 | 7 | 2018 |
Patterns of kidney function decline in autosomal dominant polycystic kidney disease: a post hoc analysis from the HALT-PKD trialsGM Brosnahan, KZ Abebe, CG Moore, FF Rahbari-Oskoui, KT Bae, …American Journal of Kidney Diseases 71 (5), 666-676 | 26 | 2018 |
FP804 TWO-YEAR DURABILITY OF IMPROVEMENTS IN EGFR WITH BARDOXOLONE METHYL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: THE LARIAT STUDYC Meyer, M Chakinala, M Chin, D Coyne, J Feldman, A Goldsberry, …Nephrology Dialysis Transplantation 33 (suppl_1), i634-i634 | | 2018 |
SP421 SODIUM ZIRCONIUM CYCLOSILICATE FOR HYPERKALAEMIA IN PATIENTS WITH DIABETES MELLITUS: RETROSPECTIVE ANALYSIS OF A 12 MONTH OPEN LABEL, PHASE 3 STUDYS Fishbane, S Roger, D Packham, P Lavin, S Adler, E Lerma, J Butler, …Nephrology Dialysis Transplantation 33 (suppl_1), i489-i490 | 3 | 2018 |
FP152 EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE-POST-HOC ANALYSIS FROM BEAM AND BEACONP Rossing, G Block, G Chertow, M Chin, A Goldsberry, P McCullough, …Nephrology Dialysis Transplantation 33 (suppl_1), i27-i27 | 1 | 2018 |